Drug Chatter -- Tracking biopharma stock chatter

Profile for OXiGENE, Inc. (OXGN)

« Back to company index

OXGN Chatter Timeline

Stock Ticker for OXGN

Most Active Tweeters for OXGN

UserTweets
@Allstocknews 1

Recent Tweets for OXGN

Allstocknews @Allstocknews
$OXGN Mateon Provides Corporate Update and Reports Third Quarter 2017 Financial Results From our Stock News Alerts App
November 14th 2017, 8:11am
Allstocknews @Allstocknews
$OXGN Mateon Therapeutics Announces Updated Data from Fifth Cohort of Phase 1b Study of OXi4503 in Acute Myel From our Stock News Alerts App
October 30th 2017, 8:10am
specstockscom @specstockscom
Get your say in on $OXGN at SpeculatingStocks, the discovery engine. No login required! #stocks https://t.co/p3wxDW5cBb
October 13th 2017, 2:10am
specstockspulse @specstockspulse
Get your say in on $OXGN at SpeculatingStocks, the discovery engine. No login required! #stocks https://t.co/O3Ny1no8ww
October 13th 2017, 2:10am
JohnLBair1 @JohnLBair1
RT @BioStocks: $MATN (fka $OXGN) Announces Termination of FOCUS Study in Ovarian Cancer. Cuts Workforce by 60% https://t.co/HGlcNGrFGb
September 26th 2017, 10:09pm
BioStocks @BioStocks
$MATN (fka $OXGN) Announces Termination of FOCUS Study in Ovarian Cancer. Cuts Workforce by 60% https://t.co/HGlcNGrFGb
September 26th 2017, 9:09pm
Allstocknews @Allstocknews
$OXGN Mateon Therapeutics Announces Termination of FOCUS Study in Ovarian Cancer and Restructuring to Priorit From our Stock News Alerts App
September 26th 2017, 6:09pm
Allstocknews @Allstocknews
$OXGN New SEC Document(s) for Mateon Therapeutics From our Stock News Alerts App
September 11th 2017, 8:09am
Allstocknews @Allstocknews
$OXGN Mateon Therapeutics to Present at the 19th Annual Rodman and Renshaw Global Investment Conference on Se From our Stock News Alerts App
September 6th 2017, 9:09am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.